Ark Therapeutics Group PLC (AKT.L)

AKT.L on London Stock Exchange

0.54GBp
26 Mar 2014
Price Change (% chg)

-0.01p (-2.65%)
Prev Close
0.56p
Open
0.55p
Day's High
0.55p
Day's Low
0.55p
Volume
1,046,691
Avg. Vol
1,452,272
52-wk High
0.83p
52-wk Low
0.28p

AKT.L

Chart for AKT.L

About

Ark Therapeutics Group plc is engaged in the provision of contract development and manufacturing services to the pharmaceutical and biotech industry. The Company’s business activity includes the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and... (more)
No analyst recommendations are available for AKT.L.

Overall

Beta: -0.03
Market Cap (Mil.): £1.12
Shares Outstanding (Mil.): 209.28
Dividend: --
Yield (%): --

Financials

  AKT.L Industry Sector
P/E (TTM): -- 32.67 33.58
EPS (TTM): -0.01 -- --
ROI: -359.03 18.00 17.30
ROE: -359.03 18.64 18.05
Search Stocks

BRIEF-Ark Therapeutics signs deal terms for reverse takeover

* Company has signed heads of terms in connection with possible acquisition of a revenue-generating and profitable uk-based private company in healthcare support services sector

28 Mar 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks